USP13 and colorectal carcinoma: In the present study, rVEGFA negated the inhibitory effect of the CM from USP13-overexpressing CRC cells against HUVEC angiogenesis, whereas VEGFA siRNA or VEGFA-neutralizing antibodies abolished the inhibitory effect of the CM in sh-USP13 CRC cells against HUVEC angiogenesis.